ROMEOVILLE, Ill. — November 11, 2025 — Leads & Copy — Solésence, Inc. (Nasdaq: SLSN) reported its third-quarter financial results, which ended September 30, 2025, and announced key changes in executive leadership, product development, and operations. Kevin Cureton has been promoted to President and Chief Executive Officer, and Laura Riffner has been appointed Chief Financial Officer. Yoana Dvorzsak will lead a newly unified group as Vice President, Innovation and Product Integrity.
According to President and Chief Executive Officer Kevin Cureton, Solésence has implemented strategic initiatives driving improvements in innovation, product quality, and operational efficiency. The company is dedicated to expanding the reach of its skin care, sun care, and color cosmetic solutions to consumers.
Third-quarter revenue was $14.5 million, compared to $16.9 million for the same period in 2024. The gross margin was 23% in the third quarter, compared to 36% for the same period in 2024. Gross profit in the third quarter was $3.4 million, compared to $6.1 million for the same period in 2024. Net loss for the third quarter was $1.1 million, compared to net income of $3.0 million for the same period in 2024.
Structural changes focused on streamlining operations, enhancing product integrity, and improving productivity, have strategically positioned Solésence for scaled growth. Riffer also said that the company reorganized vital parts of the business by unifying its R&D and Quality teams, consolidating manufacturing, and increasing production automation.
Solésence will host its third-quarter conference call on Tuesday, November 11, 2025, at 7:30 a.m. CT, 8:30 a.m. ET, to discuss its financial results and provide a business and financial update. On the call will be Kevin Cureton, President and Chief Executive Officer, Laura Riffner, Chief Financial Officer, and Jess Jankowski, Board Advisor.
The webcast link is https://edge.media-server.com/mmc/p/qur8mp24, and the dial-in link is https://register-conf.media-server.com/register/BI2e27b8a6c7664f28b7a16148b68f01ba. The call may also be accessed through the company’s investor relations website, at https://ir.solesence.com/.
Solésence, Inc. is a leader in scientifically-driven health care solutions across beauty and life science categories. The company has redefined mineral-based sun protection by maximizing transparency, effectiveness, aesthetics, and wearability, empowering individuals to embrace beauty on their own terms.
Media Contact:
media@solesence.com
Investor Relations Contact:
investors@solesence.com
Source: Solésence, Inc.
